Jeff Heimburger

Jeff Heimburger is an experienced leader and consultant with extensive expertise in marketing, strategy, and business development across various industries. Currently serving as CEO of Buzzkill Labs, Jeff is focused on modernizing drug testing within the evolving cannabis sector. Jeff also provides strategic advisory support at Thaddeus and serves on the commercial advisory board for S2 Genomics, where innovations in genomic sample processing are prioritized. Additionally, participation on the advisory board of Ausava Ai highlights a commitment to integrating AI in client-coach partnerships. Previous roles include significant marketing leadership positions at Agilent Technologies and IntegenX, as well as consulting for numerous corporations and startups. Jeff holds a Bachelor’s Degree in Mechanical Engineering with a minor in Biology from Purdue University and has furthered education at The University of Chicago Booth School of Business.